| Amy Smolucha, | |
|
4251 River Center Ct Ne, Cedar Rapids, IA 52402-7549 | |
| (312) 567-2167 | |
| Not Available |
| Full Name | Amy Smolucha |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 8 Years |
| Location | 4251 River Center Ct Ne, Cedar Rapids, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740630078 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 1740630078 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eastern Iowa Health Center | 0648364828 | 16 |
News Archive
There are many health effects that a patient may need to overcome after winning a battle against cancer. Cancer treatments can affect the patient's balance, agility, coordination, prompt weight gain and other physical ailments. At Nationwide Children's Hospital, beating cancer doesn't mark the end of a child's treatment regimen. A new exercise program at the hospital helps pediatric cancer survivors and those in remission regain both physical strength and confidence.
A new study finds that a difference in blood pressure between arms is associated with an increased risk of heart attack, stroke, and death.
Roche today announced that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for use of Tarceva(R) (erlotinib) as a maintenance therapy for people with advanced non-small cell lung cancer (NSCLC) and stable disease (cancer remains largely unchanged) after initial chemotherapy. The CHMP positive opinion clears the way for European Union approval and means that this group of patients may soon be able to benefit from earlier treatment with Tarceva.
Shire plc announces that the U.S. Food and Drug Administration has approved Xiidra (lifitegrast ophthalmic solution) 5%, a twice-daily eye drop solution indicated for the treatment of the signs and symptoms of dry eye disease in adult patients.
A study, funded by the British Heart Foundation and Medical Research Council, has shed new light on how carbon monoxide could be used to protect against life-threatening arrhythmias after a heart attack.
› Verified 7 days ago
| Entity Name | Eastern Iowa Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578753703 PECOS PAC ID: 0648364828 Enrollment ID: O20071009000505 |
News Archive
There are many health effects that a patient may need to overcome after winning a battle against cancer. Cancer treatments can affect the patient's balance, agility, coordination, prompt weight gain and other physical ailments. At Nationwide Children's Hospital, beating cancer doesn't mark the end of a child's treatment regimen. A new exercise program at the hospital helps pediatric cancer survivors and those in remission regain both physical strength and confidence.
A new study finds that a difference in blood pressure between arms is associated with an increased risk of heart attack, stroke, and death.
Roche today announced that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for use of Tarceva(R) (erlotinib) as a maintenance therapy for people with advanced non-small cell lung cancer (NSCLC) and stable disease (cancer remains largely unchanged) after initial chemotherapy. The CHMP positive opinion clears the way for European Union approval and means that this group of patients may soon be able to benefit from earlier treatment with Tarceva.
Shire plc announces that the U.S. Food and Drug Administration has approved Xiidra (lifitegrast ophthalmic solution) 5%, a twice-daily eye drop solution indicated for the treatment of the signs and symptoms of dry eye disease in adult patients.
A study, funded by the British Heart Foundation and Medical Research Council, has shed new light on how carbon monoxide could be used to protect against life-threatening arrhythmias after a heart attack.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amy Smolucha, 4251 River Center Ct Ne, Cedar Rapids, IA 52402-7549 Ph: () - | Amy Smolucha, 4251 River Center Ct Ne, Cedar Rapids, IA 52402-7549 Ph: (312) 567-2167 |
News Archive
There are many health effects that a patient may need to overcome after winning a battle against cancer. Cancer treatments can affect the patient's balance, agility, coordination, prompt weight gain and other physical ailments. At Nationwide Children's Hospital, beating cancer doesn't mark the end of a child's treatment regimen. A new exercise program at the hospital helps pediatric cancer survivors and those in remission regain both physical strength and confidence.
A new study finds that a difference in blood pressure between arms is associated with an increased risk of heart attack, stroke, and death.
Roche today announced that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for use of Tarceva(R) (erlotinib) as a maintenance therapy for people with advanced non-small cell lung cancer (NSCLC) and stable disease (cancer remains largely unchanged) after initial chemotherapy. The CHMP positive opinion clears the way for European Union approval and means that this group of patients may soon be able to benefit from earlier treatment with Tarceva.
Shire plc announces that the U.S. Food and Drug Administration has approved Xiidra (lifitegrast ophthalmic solution) 5%, a twice-daily eye drop solution indicated for the treatment of the signs and symptoms of dry eye disease in adult patients.
A study, funded by the British Heart Foundation and Medical Research Council, has shed new light on how carbon monoxide could be used to protect against life-threatening arrhythmias after a heart attack.
› Verified 7 days ago
Owen M Mccarron, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 701 10th St Se, J Edward Lundy Pavilion 4th Floor, Cedar Rapids, IA 52403 Phone: 319-221-8400 Fax: 319-221-8403 | |
Dr. Stephen Lansing Pedron, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 855 A Ave Ne Ste 120, Cedar Rapids, IA 52402 Phone: 319-297-9350 Fax: 319-297-9349 | |
Kristin Lea Orr, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 788 8th Ave Se Ste 100, Cedar Rapids, IA 52401 Phone: 319-363-2682 Fax: 319-363-1361 | |
Robin Gail Brown, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1953 1st Ave Se, Suite A2, Cedar Rapids, IA 52402 Phone: 319-365-0059 Fax: 319-365-0449 | |
Dr. Arlene Denise Parsons, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 788 8th Ave Se Ste 100, Cedar Rapids, IA 52401 Phone: 319-363-2682 Fax: 319-363-1473 | |
Lindsy Marie Alons, M.D Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 788 8th Ave Se Ste 100, Cedar Rapids, IA 52401 Phone: 319-363-2682 Fax: 319-363-1463 | |
Avery Marie Whitis, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 855 A Ave Ne Ste 200, Cedar Rapids, IA 52402 Phone: 319-368-5500 |